[go: up one dir, main page]

IL132767A0 - 9-Oxime erythromycin derivatives - Google Patents

9-Oxime erythromycin derivatives

Info

Publication number
IL132767A0
IL132767A0 IL13276798A IL13276798A IL132767A0 IL 132767 A0 IL132767 A0 IL 132767A0 IL 13276798 A IL13276798 A IL 13276798A IL 13276798 A IL13276798 A IL 13276798A IL 132767 A0 IL132767 A0 IL 132767A0
Authority
IL
Israel
Prior art keywords
erythromycin derivatives
oxime erythromycin
oxime
derivatives
erythromycin
Prior art date
Application number
IL13276798A
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of IL132767A0 publication Critical patent/IL132767A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IL13276798A 1997-06-11 1998-05-15 9-Oxime erythromycin derivatives IL132767A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4934997P 1997-06-11 1997-06-11
PCT/IB1998/000741 WO1998056800A1 (en) 1997-06-11 1998-05-15 9-oxime erythromycin derivatives

Publications (1)

Publication Number Publication Date
IL132767A0 true IL132767A0 (en) 2001-03-19

Family

ID=21959341

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13276798A IL132767A0 (en) 1997-06-11 1998-05-15 9-Oxime erythromycin derivatives

Country Status (31)

Country Link
EP (1) EP0988308A1 (en)
JP (1) JP2000513026A (en)
KR (1) KR20010013660A (en)
CN (1) CN1259135A (en)
AP (1) AP9801253A0 (en)
AR (1) AR012244A1 (en)
AU (1) AU7226798A (en)
BG (1) BG103947A (en)
BR (1) BR9810021A (en)
CA (1) CA2293335A1 (en)
CO (1) CO4940506A1 (en)
CZ (1) CZ9904388A3 (en)
EA (1) EA199901016A1 (en)
GT (1) GT199800074A (en)
HN (1) HN1998000073A (en)
HR (1) HRP980316A2 (en)
HU (1) HUP0002252A3 (en)
ID (1) ID24529A (en)
IL (1) IL132767A0 (en)
IS (1) IS5251A (en)
MA (1) MA26505A1 (en)
NO (1) NO996108L (en)
OA (1) OA11225A (en)
PA (1) PA8451801A1 (en)
PE (1) PE79899A1 (en)
PL (1) PL337606A1 (en)
TN (1) TNSN98083A1 (en)
TR (1) TR199902995T2 (en)
TW (1) TW448174B (en)
WO (1) WO1998056800A1 (en)
ZA (1) ZA985018B (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000159A (en) * 1997-10-29 1999-02-09 Monsanto Co DERIVATIVES OF 9- AMINO - 3 CETO ERITROMICINA
DE69926005T2 (en) * 1998-09-22 2006-05-18 Pfizer Products Inc., Groton CARBAMATE AND CARBAZATE KETOLIDANTIBIOTICS
FR2786188B1 (en) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc NOVEL ERYTHROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
US6258785B1 (en) 1998-12-02 2001-07-10 Pfizer Inc. Crystalline 9-E-(O-methyl)oxime of 11, 12-dideoxy-3-de(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribohexopyranosyloxy)-6-O-methyl-12,11-(iminocarbonyl-(2-(3-(4-(3-pyridinyl)1H-imadazol-1-yl)propyl)hydrazono))-3-oxoerythromycin
EP1298138B1 (en) * 1998-12-10 2006-11-02 Pfizer Products Inc. Carbamate and Carbazate Ketolide Antibiotics
US6284732B1 (en) * 1998-12-18 2001-09-04 Bio-Rad Laboratories, Inc. Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases
ES2272273T3 (en) * 1999-04-16 2007-05-01 Kosan Biosciences, Inc. MACROLID ANTI-INFECTIVE AGENTS.
AU3832100A (en) 1999-05-24 2000-12-12 Pfizer Products Inc. 13-methyl-erythromycin derivatives
MXPA01012661A (en) * 1999-06-07 2002-07-22 Abbott Lab 6-o-carbamate ketolide derivatives.
ID27331A (en) * 1999-09-29 2001-03-29 Pfizer Prod Inc MAKING ANTIBIOTIC-ANTIBIOTIC KETOLIDA CARBAMATE
EP1114826A3 (en) * 1999-12-29 2001-10-31 Pfizer Products Inc. Novel antibacterial and prokinetic macrolides
EP1439186A3 (en) * 1999-12-29 2004-11-03 Pfizer Products Inc. Intermediates for novel antibacterial and prokinetic macrolides
US6946446B2 (en) 2000-02-24 2005-09-20 Abbott Laboratories Anti-infective agents useful against multidrug-resistant strains of bacteria
US6403776B1 (en) 2000-07-05 2002-06-11 Pfizer Inc. Synthesis of carbamate ketolide antibiotics
WO2003090761A1 (en) * 2002-04-25 2003-11-06 Abbott Laboratories 9-oxime macrolide antibacterials
TW200420573A (en) 2002-09-26 2004-10-16 Rib X Pharmaceuticals Inc Bifunctional heterocyclic compounds and methods of making and using same
US7601695B2 (en) * 2003-03-10 2009-10-13 Optimer Pharmaceuticals, Inc. Antibacterial agents
EP1723159B1 (en) 2004-02-27 2019-06-12 Melinta Therapeutics, Inc. Macrocyclic compounds and methods of making and using the same
WO2009055557A1 (en) 2007-10-25 2009-04-30 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
ES2565083T3 (en) 2008-10-24 2016-03-31 Cempra Pharmaceuticals, Inc. Biodefenses using macrolides containing triazole
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
ES2608285T3 (en) 2009-09-10 2017-04-07 Cempra Pharmaceuticals, Inc. Procedures for the treatment of malaria, tuberculosis and MAC diseases
CN102146085B (en) * 2010-02-09 2014-03-26 北京理工大学 9-oxime-ether ketolide derivative, and preparation method and medical composite thereof
US8975386B2 (en) 2010-03-22 2015-03-10 Cempra Pharmaceuticals, Inc. Crystalline forms of a macrolide, and uses therefor
ES2636948T3 (en) 2010-05-20 2017-10-10 Cempra Pharmaceuticals, Inc. Processes for preparing macrolides and ketolides and intermediates for them
JP6042334B2 (en) 2010-09-10 2016-12-14 センプラ ファーマシューティカルズ,インコーポレイテッド Hydrogen bond forming fluoroketolides for disease treatment
CA2868262A1 (en) 2012-03-27 2013-10-03 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
US9861616B2 (en) 2013-03-14 2018-01-09 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
CA2907085A1 (en) 2013-03-15 2014-09-18 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2718450B1 (en) * 1994-04-08 1997-01-10 Roussel Uclaf New erythromycin derivatives, their preparation process and their use as drugs.

Also Published As

Publication number Publication date
MA26505A1 (en) 2004-12-20
AR012244A1 (en) 2000-09-27
HUP0002252A2 (en) 2000-12-28
NO996108D0 (en) 1999-12-10
TNSN98083A1 (en) 2005-03-15
NO996108L (en) 2000-02-10
OA11225A (en) 2003-07-17
CO4940506A1 (en) 2000-07-24
CZ9904388A3 (en) 2002-10-16
ID24529A (en) 2000-07-20
PE79899A1 (en) 1999-08-25
BR9810021A (en) 2000-09-19
PL337606A1 (en) 2000-08-28
HN1998000073A (en) 1999-01-08
IS5251A (en) 1999-11-16
BG103947A (en) 2000-07-31
PA8451801A1 (en) 2000-05-24
AP9801253A0 (en) 1999-12-04
HRP980316A2 (en) 1999-04-30
TR199902995T2 (en) 2000-02-21
HUP0002252A3 (en) 2002-01-28
EP0988308A1 (en) 2000-03-29
AU7226798A (en) 1998-12-30
CN1259135A (en) 2000-07-05
CA2293335A1 (en) 1998-12-17
TW448174B (en) 2001-08-01
WO1998056800A1 (en) 1998-12-17
JP2000513026A (en) 2000-10-03
KR20010013660A (en) 2001-02-26
EA199901016A1 (en) 2000-06-26
ZA985018B (en) 1999-12-10
GT199800074A (en) 1999-11-27

Similar Documents

Publication Publication Date Title
IL132767A0 (en) 9-Oxime erythromycin derivatives
IL130328A0 (en) Tricyclic erythromycin derivatives
PL348333A1 (en) Macrolides
HUP0100566A3 (en) Novel erythromycin derivatives
AU9277698A (en) 9-amino-3-keto erythromycin derivatives
HUP0001330A3 (en) 3'-n-oxide, 3'-n-dimethylamine, 9-oxime erythromycin a derivatives
IL129946A0 (en) Erythromycin a derivatives
HK1031383A1 (en) 2-Halo-5-o-substituted ketolide derivatives
ZA987688B (en) 6,9-bridged erythromycin derivatives
IL134996A0 (en) 6,11-bridged erythromycin derivatives
ZA985655B (en) Crystalline macrolides
NZ513998A (en) Erythromycin derivatives
ZA989835B (en) Erythromycin a derivatives
ZA989830B (en) Erythromycin a derivatives
AU8925398A (en) 3-descladinose 6-o-substituded erythromycin derivatives
ZA983902B (en) Erythromycin derivatives.
EP1044985A4 (en) Erythromycin derivatives
ZA981572B (en) Erythromycin a derivatives
IL115312A0 (en) Antibiotic macrolides
ZA984488B (en) Multicyclic erythromycin derivatives
GB9700702D0 (en) Erythromycin derivatives
ZA951845B (en) Acid-stabile erythromycin derivatives
ZA989845B (en) 2-halo-6-O-substituted ketolide derivatives
SI1027362T1 (en) 2-halo-6-o-substituted ketolide derivatives
ZA989848B (en) 6,11-bridged erythromycin derivatives